Cargando…
Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules
Down syndrome (DS) is the most common genomic disorder characterized by the increased incidence of developing early Alzheimer’s disease (AD). In DS, the triplication of genes on chromosome 21 is intimately associated with the increase of AD pathological hallmarks and with the development of brain re...
Autores principales: | Lanzillotta, Chiara, Di Domenico, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916967/ https://www.ncbi.nlm.nih.gov/pubmed/33670211 http://dx.doi.org/10.3390/biom11020266 |
Ejemplares similares
-
The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome
por: Zuliani, Ilaria, et al.
Publicado: (2020) -
Proteomics Study of Peripheral Blood Mononuclear Cells in Down Syndrome Children
por: Lanzillotta, Chiara, et al.
Publicado: (2020) -
Gut–Brain Axis and Neurodegeneration: State-of-the-Art of Meta-Omics Sciences for Microbiota Characterization
por: Tilocca, Bruno, et al.
Publicado: (2020) -
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
por: Tramutola, Antonella, et al.
Publicado: (2018) -
Preclinical Evidence for the Interplay between Oxidative Stress and RIP1-Dependent Cell Death in Neurodegeneration: State of the Art and Possible Therapeutic Implications
por: Jantas, Danuta, et al.
Publicado: (2021)